You searched for: pila
Danish leads among life science stocks in the first half of the year
The first half of the year is over and it's time to swap the ergonomic office chair for a lounge chair. For us...
News roundup Wednesday April 5
The latest from BioStock
The value of patent protection in life science
Inventing, developing and launching new pharmaceuticals and medical devices is a long, capital-intensive and risky process. Ownership and...
Pila Pharma expands XEN-D0501 with new indication
Malmö-based Pila Pharma announced in the spring that it had applied for orphan drug status for the drug candidate XEN-D0501 for the treatment of erythromelalgia. In...
Pila Pharma's CEO comments on the Q2 report
Malmö-based biotech company Pila Pharma is continuing steadily towards clinical phase II studies with XEN-D0501. In the second quarter of 2022...
Pila Pharma begins toxicological studies
The Malmö company Pila Pharma is in full swing with preparations for phase IIb studies with the drug candidate XEN-D0501. Before it can be started...
Deep dive into Pila Pharma's clinical concept
Type 2 diabetes is one of the most common diseases in the world. A company that wants to take a piece of the market pie...
Pila Pharma enters pain with XEN-D0501
After long having diabetes as the only track for the drug candidate XEN-D0501, Pila Pharma is now taking the next step on the journey...
Pila Pharma's CEO on company development since listing
"We're on our way". This is how the CEO's words begin when Pila Pharma's CEO Dorte X. Gram reports on the full year 2021 in the year-end report...
Novo veteran strengthens Pila Pharma
The production of study material for XEN-D0501 is underway and is expected to be completed before the summer, after which Pila Pharma can begin...
Continued high interest in life science listings in 2021
After a successful year for life science on the stock market in 2020, the skyrocketing interest in the sector continued in 2021....
Several triggers for Pila Pharma in 2022
There is no doubt that type 2 diabetes has become one of the most common diseases with more than a...